Panacea Biotec Ltd

Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and nine months ended December 31 2025.The trading window of the Company shall remain closed for all Designated Persons (including their Immediate relatives) of the Company till February 13 2026